NFKB1 and ischemic stroke: In ex vivo ischemic stroke experiments, lncRNA-1810034E14Rik may exert anti-inflammatory effects by inhibiting the NF-κB pathway and suppressing microglia activation and p65 hyperphosphorylation, with implications for stroke treatment (Zhang et al., 2019e).